Saturday, July 11, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “inhibitor”

2,878 pharma patents match "inhibitor" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,878
Index total 30,257
Page 28 / 120

Quick answer

This filtered view shows 2,878 pharmaceutical patents matching "inhibitor" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,878 results for “inhibitor” · 30,257 patents in full index Clear search

  1. US 11155549

    Ester and carbonate pyrimidine compounds as JAK kinase inhibitors

    Theravance Biopharma R&D IP, LLC · Granted Oct 26, 2021 · Expires Oct 21, 2041

    granted

  2. US 11154519

    Inhibitors and their uses

    United Kingdom Research and Innovation · Granted Oct 26, 2021 · Expires Oct 21, 2041

    granted

  3. US 11155879

    Method of predicting effects of CDC7 inhibitor

    Takeda Pharmaceutical Company Limited · Granted Oct 26, 2021 · Expires Oct 21, 2041

    granted

  4. US 11155559

    Sulfonyl-substituted isoquinolines as inhibitors of RHO kinase and hERG potassium channel activity

    CHINA RESOURCES PHARMACEUTICAL HOLDINGS COMPANY LIMITED · Granted Oct 26, 2021 · Expires Oct 21, 2041

    granted

  5. US 11147801

    Methods of use for trisubstituted benzotriazole derivatives as dihydroorotate oxygenase inhibitors

    Aurigene Discovery Technologies Limited · Granted Oct 19, 2021 · Expires Oct 14, 2041

    granted

  6. US 11147885

    ASH1L inhibitors and methods of treatment therewith

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Oct 19, 2021 · Expires Oct 14, 2041

    granted

  7. US 11141418

    Methods and compositions for KRAS inhibitors

    The Board of Regents of the University of Texas System · Granted Oct 12, 2021 · Expires Oct 7, 2041

    granted

  8. US 11135225

    Cancer treatments using combinations of CDK and ERK inhibitors

    Biomed Valley Discoveries, Inc. · Granted Oct 5, 2021 · Expires Sep 30, 2041

    granted

  9. US 11135222

    Aurora kinase inhibitors

    The Regents of the University of California · Granted Oct 5, 2021 · Expires Sep 30, 2041

    granted

  10. US 11135204

    Anhydrous compositions of mTOR inhibitors and methods of use

    PALVELLA THERAPEUTICS, INC. · Granted Oct 5, 2021 · Expires Sep 30, 2041

    granted

  11. US 11130778

    CD73 inhibitors

    ORIC PHARMACEUTICALS, INC. · Granted Sep 28, 2021 · Expires Sep 23, 2041

    granted

  12. US 11130759

    2-oxoquinazoline derivatives as methionine adenosyltransferase 2A inhibitors

    IDEAYA Biosciences, Inc. · Granted Sep 28, 2021 · Expires Sep 23, 2041

    granted

  13. US 11129808

    PKC-delta-I inhibitor formulations and uses thereof

    THE UNITED STATES GOVERNMENT AS REPRESENTED BY THE DEPARTMENT OF VETERRANS AFFAIRS OFFICE OF THE GENERAL COUNSEL · Granted Sep 28, 2021 · Expires Sep 23, 2041

    granted

  14. US 11129828

    Pyridazinone compounds and their use as DAAO inhibitors

    Takeda Pharmaceutical Company Limited · Granted Sep 28, 2021 · Expires Sep 23, 2041

    granted

  15. US 11129805

    Dual ACE C-domain/NEP inhibitors

    ANGIODESIGN (UK) LIMITED · Granted Sep 28, 2021 · Expires Sep 23, 2041

    granted

  16. US 11129841

    CD73 inhibitors

    ORIC PHARMACEUTICALS, INC. · Granted Sep 28, 2021 · Expires Sep 23, 2041

    granted

  17. US 11129856

    Methods of treating chronic wounds with amniotic fluid having elevated levels of tissue inhibitors of matrix metalloproteinases

    Prime Merger Sub, LLC · Granted Sep 28, 2021 · Expires Sep 23, 2041

    granted

  18. US 11124839

    Methods of treating cancer patients with farnesyltransferase inhibitors

    Kura Oncology, Inc. · Granted Sep 21, 2021 · Expires Sep 16, 2041

    granted

  19. US 11124502

    Neprilysin inhibitors

    Theravance Biopharma R&D IP, LLC · Granted Sep 21, 2021 · Expires Sep 16, 2041

    granted

  20. US 11123340

    Small-molecule UT-A-selective urea transport inhibitors

    The Regents of the University of California · Granted Sep 21, 2021 · Expires Sep 16, 2041

    granted

  21. US 11124537

    Inhibitors of glucocorticoid receptor

    ORIC PHARMACEUTICALS, INC. · Granted Sep 21, 2021 · Expires Sep 16, 2041

    granted

  22. US 11117900

    Compounds useful as inhibitors of ATR kinase

    Vertex Pharmaceuticals Incorporated · Granted Sep 14, 2021 · Expires Sep 9, 2041

    granted

  23. US 11116839

    Methods for reducing lipoprotein(a) levels by administering an inhibitor of proprotein convertase subtilisin kexin-9 (PCSK9)

    REGENERON PHARMACEUTICALS, INC. · Granted Sep 14, 2021 · Expires Sep 9, 2041

    granted

  24. US 11117899

    [1,2,4]triazolo[1,5-c]pyrimidine derivative as A2A receptor inhibitor

    Medshine Discovery Inc. · Granted Sep 14, 2021 · Expires Sep 9, 2041

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.